期刊文献+

重症肺炎临床及预后因素分析 被引量:107

Clinical Aspects and Prognostic Factors of Severe Pneumonia
下载PDF
导出
摘要 目的了解重症肺炎流行病学、病原学、临床诊治现状及预后相关因素。方法以中山大学附属第一医院出院符合重症肺炎诊断标准的病例为研究对象,采用回顾性病例对照研究及Logistic回归分析其预后相关因素。结果重症社区获得性肺炎(SCAP)病死率为45.0%,重症医院获得性肺炎(SHAP)为58.5%;高龄、心功能不全、人工气道和感染性休克为SCAP的预后危险因素,初始抗菌药物联合用药为保护性因素;心功能不全、感染性休克、心动过速为SHAP的预后危险因素。结论肺炎所致严重系统炎症反应是重症肺炎主要的预后危险因素,尽早进行足量抗菌药物经验治疗对疾病预后有重要影响。 OBJECTIVE To conclude and analyze epidemiology, etiology, diagnostic, treatment and prognostic factors of local adult hospitalized patients with severe pneumonia. METHODS A retrospective analysis with case- control study was designed. All the medical records of consecutive patients aged ≥ 18 yrs with diagnosis of pneumonia from Sep 2000 to Sep 2005 in the First Affiliated Hospital of Sun Yat-sen University were searched. Contribution of the factors to prognosis was determined by multivariate analysis with Logistic regression. RESULTS In the severe community-acquired pneumonia (SCAP) subgroup, mortality was 45.0%; and in the severe hospital-acquired pneumonia (SHAP) subgroup, mortality was 54. 8%. In the SCAP subgroup, there were five factors associated with prognosis on multivariate analysis: age (≥75yrs), heart failure, intubation and septic shock were risk factors; initial combined antibiotic therapy was protective factors. In the SHAP subgroup, factors associated with prognosis on multivariate analysis were heart failure, septic shock and heart rate ≥ 100bpm; all were risk factors, CONCLUSIONS Septic shock and heart failure are associated with mortality both in SCAP and SHAP, which suggest that severe systemic inflammatory response associated with the pulmonary infection be an important prognostic factor in the outcome of severe pneumonia. Initial appropriate antibiotic empiric therapy was important to the prognosis.
作者 易慧 谢灿茂
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2008年第1期56-58,共3页 Chinese Journal of Nosocomiology
关键词 重症肺炎 预后因素 感染性休克 LOGISTIC回归 Severe pneumonia Prognostic factors Septic shock Logistic regression
  • 相关文献

参考文献12

  • 1[1]American Thoracic Society.Guidelines for the management of adults with community acquired pneumonia[J].Am J Crit Care Med,2001,163(7):1730-1754.
  • 2[2]American Thoracic Society,Infectious Diseases Society of America.Guidelines for the management of adults with hospital-acquired,ventilator-associated,and healthcare-associated pneumonia[J].Am J Respir Crit Care,2005,171(4):388-416.
  • 3[3]Paganin F,Lilienthal F,Bourdin A,et al.Severe community-acquired pneumonia:assessment of microbial aetiology as mortality factor[J].Eur Respir J,2004,24(5):779-785.
  • 4[4]Rello J,Bodi M,Mariscal D,et al.Microbiological testing and outcome of patients with severe community-acquired pneumonia[J].Chest,2003,123(1):174-180.
  • 5吴安华,任南,文细毛,徐秀华.全国医院感染监控网1998~1999年监测资料分析[J].中华医院感染学杂志,2000,10(6):401-403. 被引量:443
  • 6胡必杰,何礼贤,张杏怡,董伟贤,李锡莹.我国医院内肺炎流行病学现状:20世纪90年代发表论文的荟萃分析[J].中华医院感染学杂志,2001,11(3):177-180. 被引量:82
  • 7[7]Valles J,Mesalles E,Mariscal D,et al.A 7-year study of severe hospital-acquired pneumonia requiring ICU admission[J].Intensive Care Med,2003,29(11):1981-1988.
  • 8[8]Wilson PA,Ferguson J.Severe community-acquired pneumonia:an Australian perspective[J].Intern Med J,2005,35(12):699-705.
  • 9[9]Martinez JA,Horcajada JP,Almela M,et al.Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia[J].Clin Infect Dis,2003,36(4):389-395.
  • 10[10]Baddour LM,Yu VL,Klugman KP,et al.Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia[J].Am J Respir Crit Care Med,2004,170(4):440-444.

二级参考文献23

共引文献618

同被引文献928

引证文献107

二级引证文献994

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部